| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT07033585 | Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With… | Type 2 Diabetes | Active, Not Recruiting |
| NCT01064466 | Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms | Small Cell Lung Cancer | Active, Not Recruiting |
| NCT07145333 | Pharmacogenomics ANDA SNP Clinical Study - Topotecan and Single Nucleotide Polymorphisms | SCLC | Active, Not Recruiting |
| NCT06062810 | Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms | Breast Cancer | Active, Not Recruiting |
| NCT03348670 | Pharmacogenomics IND Commercial SNP Clinical Study - Abiraterone and Single Nucleotide… | Prostate Cancer | Active, Not Recruiting |
| NCT05987956 | Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | Active, Not Recruiting |
| Phase 1 | |||
| NCT02403505 | Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA… | Rectal Cancer | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT07182838 | Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic… | HIV Infections | Active, Not Recruiting |
| NCT06959563 | Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV | HPV Infection | Active, Not Recruiting |
| NCT03305341 | Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation… | Covid19 | Active, Not Recruiting |